-
Je něco špatně v tomto záznamu ?
Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al
HV. Olesen, P. Drevinek, VA. Gulmans, E. Hatziagorou, A. Jung, M. Mei-Zahav, N. Stojnic, M. Thomas, A. Zolin, ECFSPR Steering Group
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- cystická fibróza * komplikace diagnóza epidemiologie genetika MeSH
- diabetes mellitus * diagnóza epidemiologie etiologie MeSH
- dítě MeSH
- dospělí MeSH
- exokrinní pankreatická insuficience * diagnóza epidemiologie etiologie MeSH
- infekce dýchací soustavy * epidemiologie etiologie mikrobiologie MeSH
- lidé MeSH
- mutace MeSH
- nutriční stav MeSH
- odhad potřeb MeSH
- prevalence MeSH
- protein CFTR genetika MeSH
- respirační funkční testy metody statistika a číselné údaje MeSH
- rizikové faktory MeSH
- sexuální faktory MeSH
- věkové faktory MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: Cystic fibrosis related diabetes (CFRD) has implications for morbidity and mortality with several risk factors identified. We studied the epidemiology of CFRD in the large dataset of the European Cystic Fibrosis Society Patient registry. METHODS: Data on CF patients were investigated for the prevalence of CFRD as well as for any association with suggested risk factors and effects. RESULTS: CFRD increased by approximately ten percentage points every decade from ten years of age. Prevalence was higher in females in the younger age groups. CFRD was associated with severe CF genotypes (OR = 3.11, 95%CI: 2.77-3.48), pancreatic insufficiency (OR = 1.46, 95%CI: 1.39-1.53) and female gender (OR = 1.28, 95%CI: 1.21-1.34). Patients with CFRD had higher odds of being chronically infected with Pseudomonas aeruginosa, Burkholderia cepacia complex and Stenotrophomonas maltophilia than patients without CFRD, higher odds of having FEV1% of predicted <40% (OR = 1.82, 95%CI: 1.70-1.94) and higher odds of having BMI SDS ≤-2 than patients without CFRD (OR = 1.24, 95%CI: 1.15-1.34). CONCLUSIONS: Severe genotype, pancreatic insufficiency and female gender remain considerable intrinsic risk factors for early acquisition of CFRD. CFRD is associated with infections, lower lung function and poor nutritional status. Early diagnosis and aggressive treatment of CFRD are more important than ever with increasing life span.
Belgian Cystic Fibrosis Registry Sciensano Belgium
Department of Clinical Sciences and Community Health University of Milan Milan Italy
Department of Pulmonology Mother and Child Healthcare Institute of Serbia Belgrade Serbia
Dept of Pediatrics and Adolescent Medicine Aarhus University Hospital Denmark
Dutch Cystic Fibrosis Foundation Baarn The Netherlands
Paediatric Pulmonology University Children`s Hospital Zurich Zurich Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026750
- 003
- CZ-PrNML
- 005
- 20211026132640.0
- 007
- ta
- 008
- 211013s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jcf.2019.10.009 $2 doi
- 035 __
- $a (PubMed)31680042
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Olesen, Hanne V $u Dept of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark. Electronic address: hvo@dadlnet.dk
- 245 10
- $a Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al / $c HV. Olesen, P. Drevinek, VA. Gulmans, E. Hatziagorou, A. Jung, M. Mei-Zahav, N. Stojnic, M. Thomas, A. Zolin, ECFSPR Steering Group
- 520 9_
- $a BACKGROUND: Cystic fibrosis related diabetes (CFRD) has implications for morbidity and mortality with several risk factors identified. We studied the epidemiology of CFRD in the large dataset of the European Cystic Fibrosis Society Patient registry. METHODS: Data on CF patients were investigated for the prevalence of CFRD as well as for any association with suggested risk factors and effects. RESULTS: CFRD increased by approximately ten percentage points every decade from ten years of age. Prevalence was higher in females in the younger age groups. CFRD was associated with severe CF genotypes (OR = 3.11, 95%CI: 2.77-3.48), pancreatic insufficiency (OR = 1.46, 95%CI: 1.39-1.53) and female gender (OR = 1.28, 95%CI: 1.21-1.34). Patients with CFRD had higher odds of being chronically infected with Pseudomonas aeruginosa, Burkholderia cepacia complex and Stenotrophomonas maltophilia than patients without CFRD, higher odds of having FEV1% of predicted <40% (OR = 1.82, 95%CI: 1.70-1.94) and higher odds of having BMI SDS ≤-2 than patients without CFRD (OR = 1.24, 95%CI: 1.15-1.34). CONCLUSIONS: Severe genotype, pancreatic insufficiency and female gender remain considerable intrinsic risk factors for early acquisition of CFRD. CFRD is associated with infections, lower lung function and poor nutritional status. Early diagnosis and aggressive treatment of CFRD are more important than ever with increasing life span.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a cystická fibróza $x komplikace $x diagnóza $x epidemiologie $x genetika $7 D003550
- 650 _2
- $a protein CFTR $x genetika $7 D019005
- 650 12
- $a diabetes mellitus $x diagnóza $x epidemiologie $x etiologie $7 D003920
- 650 12
- $a exokrinní pankreatická insuficience $x diagnóza $x epidemiologie $x etiologie $7 D010188
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a odhad potřeb $7 D020380
- 650 _2
- $a nutriční stav $7 D009752
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a respirační funkční testy $x metody $x statistika a číselné údaje $7 D012129
- 650 12
- $a infekce dýchací soustavy $x epidemiologie $x etiologie $x mikrobiologie $7 D012141
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a sexuální faktory $7 D012737
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Drevinek, Pavel $u Department of Medical Microbiology, Motol University Hospital and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: pavel.drevinek@lfmotol.cuni.cz
- 700 1_
- $a Gulmans, Vincent A $u Dutch Cystic Fibrosis Foundation (NCFS), Baarn, The Netherlands. Electronic address: V.Gulmans@ncfs.nl
- 700 1_
- $a Hatziagorou, Elpis $u Paediatric Pulmonology and CF Unit, Hippokration Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, Greece
- 700 1_
- $a Jung, Andreas $u Paediatric Pulmonology, University Children`s Hospital Zurich, Zurich, Switzerland. Electronic address: andreas.jung@kispi.uzh.ch
- 700 1_
- $a Mei-Zahav, Meir $u Pulmonary Institute, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Israel
- 700 1_
- $a Stojnic, Natasa $u Department of Pulmonology, Mother and Child Healthcare Institute of Serbia, Belgrade, Serbia
- 700 1_
- $a Thomas, Muriel $u Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. Electronic address: Muriel.thomas@sciensano.be
- 700 1_
- $a Zolin, Anna $u Belgian Cystic Fibrosis Registry, Sciensano, Belgium. Electronic address: anna.zolin@unimi.it
- 710 2_
- $a ECFSPR Steering Group
- 773 0_
- $w MED00006892 $t Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society $x 1873-5010 $g Roč. 19, č. 2 (2020), s. 321-327
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31680042 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132646 $b ABA008
- 999 __
- $a ok $b bmc $g 1715482 $s 1147257
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 19 $c 2 $d 321-327 $e 20191031 $i 1873-5010 $m Journal of cystic fibrosis $n J Cyst Fibros $x MED00006892
- LZP __
- $a Pubmed-20211013
